Buy, sell or hold: What should you do with Supriya Lifescience after solid debut?
NEW DELHI: After a strong entry on D-Street, analysts recommended holding Supriya Lifescience stock for some time as it is a long-term play in the Active Pharmaceutical Ingredient (API) segment. Supriya Lifescience shares listed at Rs 425 per share against the issue price of Rs 274, amidst positive market sentiments, meaning a premium of 55 … Read more